"A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences (NCATS) and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business. The drug c"...
RIXUBIS is contraindicated in patients who have:
Last reviewed on RxList: 2/29/2016
Additional Rixubis Information
Report Problems to the Food and Drug Administration
Find out what women really need.